Literature DB >> 11029344

Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10.

S Lim1, N Roche, B G Oliver, W Mattos, P J Barnes, K F Chung.   

Abstract

An imbalance between proteases and antiproteases may play a role in emphysema, which is characterized by increased degradation of extracellular matrix, and in airway remodeling in chronic bronchitis and asthma, in which there is increased collagen deposition. We assessed the effect of smoking on release of matrix metalloprotease-9 (MMP-9) and of its inhibitor, tissue inhibitor of metalloprotease-1 (TIMP-1), from alveolar macrophages, and determined the effects of proinflammatory (interleukin [IL]-1beta and lipopolysaccharide [LPS]) and antiinflammatory (IL-10) stimuli on the release of MMP-9 and TIMP-1. We performed bronchoalveolar lavage in 11 smokers and 11 nonsmokers, and cultured airway macrophages in the presence of control medium, IL-1beta, and LPS. Airway macrophages from smokers released greater amounts of MMP-9 and TIMP-1 at baseline and in response to IL-1beta and LPS than did those of nonsmokers. Airway macrophages from smokers produced more TNF-alpha and IL-10. IL-10 increased TIMP-1 release without modifying that of MMP-9, leading to a decrease in the MMP-9 to TIMP-1 ratio. Anti-IL-10 antibody had no effect on MMP-9 production induced by LPS. We conclude that the release of proteases and antiproteases by airway macrophages is increased in cigarette smokers, and can be regulated by exogenous IL-10.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029344     DOI: 10.1164/ajrccm.162.4.9910097

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  62 in total

1.  Emphysema mediated by lung overexpression of ADAM10.

Authors:  Hiroki Saitoh; Philip L Leopold; Ben-Gary Harvey; Timothy P O'Connor; Stefan Worgall; Neil R Hackett; Ronald G Crystal
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

2.  Low Vitamin D Status Is Associated with Inflammation in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Lin Fu; Jun Fei; Zhu-Xia Tan; Yuan-Hua Chen; Biao Hu; Hui-Xiang Xiang; Hui Zhao; De-Xiang Xu
Journal:  J Immunol       Date:  2020-12-23       Impact factor: 5.422

Review 3.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

Review 4.  Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Proc Am Thorac Soc       Date:  2005

Review 5.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

6.  Correlation of matrix metalloproteinase-2 and -9 expression with recurrences in primary spontaneous pneumothorax patients.

Authors:  Wen-Chin Chiu; Yi-Chen Lee; Yu-Han Su; Chee-Yin Chai; Stephen Chu-Sung Hu; Shyng-Shiou F Yuan; Shah-Hwa Chou
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

7.  Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation.

Authors:  Jason W Chien; Lue Ping Zhao; John A Hansen; Wen Hong Fan; Tanyalak Parimon; Joan G Clark
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

8.  Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract.

Authors:  Sang Eun Kim; Tran Thi Thanh Thuy; Ji Hyun Lee; Jai Youl Ro; Young An Bae; Yoon Kong; Jee Yin Ahn; Dong Soon Lee; Yeon Mock Oh; Sang Do Lee; Yun Song Lee
Journal:  Exp Mol Med       Date:  2009-04-30       Impact factor: 8.718

Review 9.  Particulate matter air pollution and respiratory impact on humans and animals.

Authors:  Caterina Losacco; Antonella Perillo
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-04       Impact factor: 4.223

Review 10.  Biological targets for therapeutic interventions in COPD: clinical potential.

Authors:  Girolamo Pelaia; Alessandro Vatrella; Luca Gallelli; Teresa Renda; Mario Caputi; Rosario Maselli; Serafino A Marsico
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.